A meta-analysis of randomized double-blind clinical trials in CMT1A to assess the change from baseline in CMTNS and ONLS scales after one year of treatment

CMT1A is the most common inherited peripheral neuropathy. There is currently no approved treatment. We performed a meta-analysis including four randomized, double-blind, Placebo-controlled clinical trials to assess the disease progression after one year under Placebo, Ascorbic Acid (AA) or PXT3003,...

Full description

Saved in:
Bibliographic Details
Published in:Orphanet J Rare Dis
Main Authors: Mandel, Jonas, Bertrand, Viviane, Lehert, Philippe, Attarian, Shahram, Magy, Laurent, Micallef, Joëlle, Chumakov, Ilya, Scart-Grès, Catherine, Guedj, Mickael, Cohen, Daniel
Format: Artigo
Language:Inglês
Published: BioMed Central 2015
Subjects:
Letter to the Editor
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4482281/
https://ncbi.nlm.nih.gov/pubmed/26070802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-015-0293-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items